MyFinsight
Home
Blog
About
Cash and cash
equivalents
$6,463K
(-70.05%↓ Y/Y)
Prepaid expenses and
other current...
$4,932K
(-10.05%↓ Y/Y)
Prepaid expenses and
other current...
$1,055K
(-40.40%↓ Y/Y)
Accounts
receivable-Related Party
$557K
(-84.19%↓ Y/Y)
Total current assets
$13,007K
(-60.00%↓ Y/Y)
Property and equipment,
net
$11,433K
(-41.65%↓ Y/Y)
Operating lease
right-of-use assets
$7,239K
(-43.64%↓ Y/Y)
Restricted cash
$1,426K
(-59.59%↓ Y/Y)
Total assets
$33,105K
(-51.70%↓ Y/Y)
Accumulated deficit
-$375,543K
(-15.20%↓ Y/Y)
Total liabilities and
stockholders equity...
$33,105K
(-51.70%↓ Y/Y)
Total stockholders
equity (deficit)
-$3,401K
(-113.80%↓ Y/Y)
Additional paid-in capital
$372,139K
(6.13%↑ Y/Y)
Common stock, 0.0001
par value...
$3K
(0.00%↑ Y/Y)
Total liabilities
$36,506K
(-16.82%↓ Y/Y)
Total current
liabilities
$15,765K
(57.86%↑ Y/Y)
Operating lease
liabilities, non-current
$12,741K
(-51.61%↓ Y/Y)
Other non-current
liabilities
$8,000K
(5.69%↑ Y/Y)
Accrued expenses and
other current...
$4,082K
(12.51%↑ Y/Y)
Convertible notes - related
party
$3,993K
Operating lease
liabilities, current
$3,492K
(-29.87%↓ Y/Y)
Accounts payable
$2,248K
(120.39%↑ Y/Y)
Genefab sublease
deferred income - related...
$1,939K
(438.61%↑ Y/Y)
Deferred revenue -
related party
$11K
Back
Back
Balance Sheet
Senti Biosciences Holdings, Inc. (SNTI)
Senti Biosciences Holdings, Inc. (SNTI)
source: myfinsight.com